Literature DB >> 22915597

Mechanisms of self-association of a human monoclonal antibody CNTO607.

Deidra Bethea1, Sheng-Jiun Wu, Jinquan Luo, Linus Hyun, Eilyn R Lacy, Alexey Teplyakov, Steven A Jacobs, Karyn T O'Neil, Gary L Gilliland, Yiqing Feng.   

Abstract

Some antibodies have a tendency to self-associate leading to precipitation at relatively low concentrations. CNTO607, a monoclonal antibody, precipitates irreversibly in phosphate-buffered saline at concentrations above 13 mg/ml. Previous mutagenesis work based on the Fab crystal structure pinpointed a three residue fragment in the heavy chain CDR-3, (99)FHW(100a), as an aggregation epitope that is anchored by two salt bridges. Biophysical characterization of variants reveals that F99 and W100a, but not H100, contribute to the intermolecular interaction. A K210T/K215T mutant designed to disrupt the charge interactions in the aggregation model yielded an antibody that does not precipitate but forms reversible aggregates. An isotype change from IgG1 to IgG4 prevents the antibody from precipitating at low concentration yet the solution viscosity is elevated. To further understand the nature of the antibody self-association, studies on the Fab fragment found high solubility but significant self- and cross-interactions remain. Dynamic light scattering data provides evidence for higher order Fab structure at increased concentrations. Our results provide direct support for the aggregation model that CNTO607 precipitation results primarily from the specific interaction of the Fab arms of neighboring antibodies followed by the development of an extensive network of antibodies inducing large-scale aggregation and precipitation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915597     DOI: 10.1093/protein/gzs047

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  29 in total

1.  High throughput detection of antibody self-interaction by bio-layer interferometry.

Authors:  Tingwan Sun; Felicia Reid; Yuqi Liu; Yuan Cao; Patricia Estep; Claire Nauman; Yingda Xu
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

2.  Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.

Authors:  Qun Du; Melissa Damschroder; Timothy M Pabst; Alan K Hunter; William K Wang; Haibin Luo
Journal:  MAbs       Date:  2019-04-14       Impact factor: 5.857

3.  In vitro and in silico assessment of the developability of a designed monoclonal antibody library.

Authors:  Adriana-Michelle Wolf Pérez; Pietro Sormanni; Jonathan Sonne Andersen; Laila Ismail Sakhnini; Ileana Rodriguez-Leon; Jais Rose Bjelke; Annette Juhl Gajhede; Leonardo De Maria; Daniel E Otzen; Michele Vendruscolo; Nikolai Lorenzen
Journal:  MAbs       Date:  2019-01-18       Impact factor: 5.857

4.  High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Authors:  Yuqi Liu; Isabelle Caffry; Jiemin Wu; Steven B Geng; Tushar Jain; Tingwan Sun; Felicia Reid; Yuan Cao; Patricia Estep; Yao Yu; Maximiliano Vásquez; Peter M Tessier; Yingda Xu
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

5.  Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.

Authors:  James C Geoghegan; Ryan Fleming; Melissa Damschroder; Steven M Bishop; Hasige A Sathish; Reza Esfandiary
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

6.  Estimating and leveraging protein diffusion on ion-exchange resin surfaces.

Authors:  Ohnmar Khanal; Vijesh Kumar; Fabrice Schlegel; Abraham M Lenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

7.  Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAs.

Authors:  Tiffany F Chen; Stephen L Sazinsky; Damian Houde; David J DiLillo; Julie Bird; Kevin K Li; George T Cheng; Huawei Qiu; John R Engen; Jeffrey V Ravetch; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-07-08       Impact factor: 5.469

8.  Protein solubilization: a novel approach.

Authors:  David H Johnson; W William Wilson; Lawrence J DeLucas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-09-16       Impact factor: 3.205

9.  Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.

Authors:  Jayant Arora; Yue Hu; Reza Esfandiary; Hasige A Sathish; Steven M Bishop; Sangeeta B Joshi; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2016-08-25       Impact factor: 5.857

10.  Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics.

Authors:  Sahithi Ravuluri; Rohit Bansal; Nidhi Chhabra; Anurag S Rathore
Journal:  Pharm Res       Date:  2018-05-14       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.